MEDIFAST End Period Cash Flow from 2010 to 2025

MED Stock  USD 14.36  0.38  2.72%   
MEDIFAST INC's End Period Cash Flow is increasing over the years with slightly volatile fluctuation. Overall, End Period Cash Flow is expected to go to about 95.5 M this year. During the period from 2010 to 2025 MEDIFAST INC End Period Cash Flow annual values regression line had geometric mean of  43,811,398 and mean square error of 625 T. View All Fundamentals
 
End Period Cash Flow  
First Reported
1996-09-30
Previous Quarter
115.3 M
Current Value
90.9 M
Quarterly Volatility
48.4 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check MEDIFAST INC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MEDIFAST INC's main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.8 M, Interest Expense of 5 M or Selling General Administrative of 235.3 M, as well as many indicators such as Price To Sales Ratio of 0.3, Dividend Yield of 0.0035 or PTB Ratio of 0.87. MEDIFAST financial statements analysis is a perfect complement when working with MEDIFAST INC Valuation or Volatility modules.
  
Check out the analysis of MEDIFAST INC Correlation against competitors.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

Latest MEDIFAST INC's End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of MEDIFAST INC over the last few years. It is MEDIFAST INC's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MEDIFAST INC's overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Slightly volatile
   End Period Cash Flow   
       Timeline  

MEDIFAST End Period Cash Flow Regression Statistics

Arithmetic Mean67,478,338
Geometric Mean43,811,398
Coefficient Of Variation60.76
Mean Deviation32,818,670
Median76,974,000
Standard Deviation41,001,324
Sample Variance1681.1T
Range163.4M
R-Value0.81
Mean Square Error625T
R-Squared0.65
Significance0.0002
Slope6,959,113
Total Sum of Squares25216.6T

MEDIFAST End Period Cash Flow History

202595.5 M
202490.9 M
202394.4 M
202287.7 M
2021104.2 M
2020163.7 M
201977 M

About MEDIFAST INC Financial Statements

MEDIFAST INC stakeholders use historical fundamental indicators, such as MEDIFAST INC's End Period Cash Flow, to determine how well the company is positioned to perform in the future. Although MEDIFAST INC investors may analyze each financial statement separately, they are all interrelated. For example, changes in MEDIFAST INC's assets and liabilities are reflected in the revenues and expenses on MEDIFAST INC's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in MEDIFAST INC. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
End Period Cash Flow90.9 M95.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:
Check out the analysis of MEDIFAST INC Correlation against competitors.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.87)
Earnings Share
0.19
Revenue Per Share
55.12
Quarterly Revenue Growth
(0.38)
Return On Assets
0.0324
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.